Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 108486, 9 pages
http://dx.doi.org/10.1155/2013/108486
Research Article

Cornel Iridoid Glycoside Attenuates Tau Hyperphosphorylation by Inhibition of PP2A Demethylation

1Department of Pharmacology, Xuanwu Hospital of Capital Medical University, Key Laboratory for Neurodegenerative Diseases of Ministry of Education, 45 Changchun Street, Beijing 100053, China
2Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
3First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Laboratory of Molecular Biology, Tianjin 300193, China

Received 26 September 2013; Accepted 16 November 2013

Academic Editor: Jingyu Yang

Copyright © 2013 Cui-cui Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Chang, E. E. Congdon, N. S. Honson, K. E. Duff, and J. Kuret, “Structure-activity relationship of cyanine tau aggregation inhibitors,” Journal of Medicinal Chemistry, vol. 52, no. 11, pp. 3539–3547, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. J.-Z. Wang, I. Grundke-Iqbal, and K. Iqbal, “Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration,” European Journal of Neuroscience, vol. 25, no. 1, pp. 59–68, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. D. P. Hanger, B. H. Anderton, and W. Noble, “Tau phosphorylation: the therapeutic challenge for neurodegenerative disease,” Trends in Molecular Medicine, vol. 15, no. 3, pp. 112–119, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Li, M. O. Chohan, I. Grundke-Iqbal, and K. Iqbal, “Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau,” Acta Neuropathologica, vol. 113, no. 5, pp. 501–511, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Noble, D. P. Hanger, C. C. Miller, and S. Lovestone, “The importance of tau phosphorylation for neurodegenerative diseases,” Frontiers in Neurology, vol. 4, p. 83, 2013. View at Google Scholar
  6. T. Rodriguez-Martin, I. Cuchillo-Ibáñez, W. Noble, F. Nyenya, B. H. Anderton, and D. P. Hanger, “Tau phosphorylation affects its axonal transport and degradation,” Neurobiology of Aging, vol. 34, no. 9, pp. 2146–2157, 2013. View at Google Scholar
  7. A. Boutajangout, E. M. Sigurdsson, and P. K. Krishnamurthy, “Tau as a therapeutic target for alzheimer's disease,” Current Alzheimer Research, vol. 8, no. 6, pp. 666–677, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. G.-G. Xu, Y.-Q. Deng, S.-J. Liu, H.-L. Li, and J.-Z. Wang, “Prolonged Alzheimer-like tau hyperphosphorylation induced by simultaneous inhibition of phosphoinositol-3 kinase and protein kinase C in N2a cells,” Acta Biochimica et Biophysica Sinica, vol. 37, no. 5, pp. 349–354, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. S. J. Liu, A. H. Zhang, H. L. Li et al., “Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory,” Journal of Neurochemistry, vol. 87, no. 6, pp. 1333–1344, 2003. View at Google Scholar · View at Scopus
  10. Y. Wang, J.-X. Zhang, X.-X. Du et al., “Temporal correlation of the memory deficit with Alzheimer-like lesions induced by activation of glycogen synthase kinase-3,” Journal of Neurochemistry, vol. 106, no. 6, pp. 2364–2374, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Q. Yao, X. C. Li, X. X. Zhang et al., “Glycogen synthase kinase-3beta regulates leucine-309 demethylation of protein phosphatase-2A via PPMT1 and PME-1,” FEBS Letters, vol. 586, no. 16, pp. 2522–2528, 2012. View at Google Scholar
  12. Y. C. Dou, “Clinical application analysis of cornus officimalis,” Journal of Shandong University of Traditional Chinese Medicine, vol. 34, no. 4, pp. 313–314, 2010. View at Google Scholar
  13. J. F. Liang and C. Qin, “Advances in traditional Chinese medicine to treat Alzheimer's disease,” Shandong Journal of Traditional Chinese Medicine, vol. 29, no. 8, pp. 576–578, 2010. View at Google Scholar
  14. R.-Q. Yao, L. Zhang, W. Wang, and L. Li, “Cornel iridoid glycoside promotes neurogenesis and angiogenesis and improves neurological function after focal cerebral ischemia in rats,” Brain Research Bulletin, vol. 79, no. 1, pp. 69–76, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. B.-L. Ya, C.-Y. Li, L. Zhang, W. Wang, and L. Li, “Cornel iridoid glycoside inhibits inflammation and apoptosis in brains of rats with focal cerebral Ischemia,” Neurochemical Research, vol. 35, no. 5, pp. 773–781, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. L.-H. Zhao, Y.-X. Ding, L. Zhang, and L. Li, “Cornel iridoid glycoside improves memory ability and promotes neuronal survival in fimbria-fornix transected rats,” European Journal of Pharmacology, vol. 647, no. 1–3, pp. 68–74, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Reiniger, A. Lukic, J. Linehan et al., “Tau, prions and Aβ: the triad of neurodegeneration,” Acta Neuropathologica, vol. 121, no. 1, pp. 5–20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Georgievska, J. Sandin, J. Doherty et al., “AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans,” Journal of Neurochemistry, vol. 125, no. 3, pp. 446–456, 2013. View at Google Scholar
  19. M. Takahashi, K. Tomizawa, R. Kato et al., “Localization and developmental changes of τ protein kinase I/glycogen synthase kinase-3β in rat brain,” Journal of Neurochemistry, vol. 63, no. 1, pp. 245–255, 1994. View at Google Scholar · View at Scopus
  20. S. Y. Yoon, H. I. Choi, J. E. Choi, C. A. Sul, J. M. Choi, and D. H. Kim, “Methotrexate decreases PP2A methylation and increases tau phosphorylation in neuron,” Biochemical and Biophysical Research Communications, vol. 363, no. 3, pp. 811–816, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. J. C. Bryant, R. S. Westphal, and B. E. Wadzinski, “Methylated C-terminal leucine residue of PP2A catalytic subunit is important for binding of regulatory Bα subunit,” Biochemical Journal, vol. 339, part 2, pp. 241–246, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Tolstykh, J. Lee, S. Vafai, and J. B. Stock, “Carboxyl methylation regulates phosphoprotein phosphatase 2A by controlling the association of regulatory B subunits,” The EMBO Journal, vol. 19, no. 21, pp. 5682–5691, 2000. View at Google Scholar · View at Scopus
  23. M. Obulesu, R. Venu, and R. Somashekhar, “Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology,” Neurochemical Research, vol. 36, no. 8, pp. 1329–1335, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. M. A. Meraz-Ríos, K. I. Lira-De León, V. Campos-Peña, M. A. de Anda-Hernández, and R. Mena-López, “Tau oligomers and aggregation in Alzheimer's disease,” Journal of Neurochemistry, vol. 112, no. 6, pp. 1353–1367, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. K. M. Osiecka, H. Nieznanska, K. J. Skowronek, J. Jozwiak, and K. Nieznanski, “Tau inhibits tubulin oligomerization induced by prion protein,” Biochimica et Biophysica Acta, vol. 1813, no. 10, pp. 1845–1853, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Iqbal, I. Grundke-Iqbal, A. J. Smith, L. George, Y.-C. Tung, and T. Zaidi, “Identification and localization of a τ peptide to paired helical filaments of Alzheimer disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 14, pp. 5646–5650, 1989. View at Google Scholar · View at Scopus
  27. C.-X. Gong, F. Liu, I. Grundke-Iqbal, and K. Iqbal, “Post-translational modifications of tau protein in Alzheimer's disease,” Journal of Neural Transmission, vol. 112, no. 6, pp. 813–838, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Liu, Z. Liang, and C. X. Gong, “Hyperphosphorylation of tau and protein phosphatases in Alzheimer disease,” Panminerva Medica, vol. 48, no. 2, pp. 97–108, 2006. View at Google Scholar · View at Scopus
  29. D. P. Hanger, H. L. Byers, S. Wray et al., “Novel phosphorylation sites in Tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis,” Journal of Biological Chemistry, vol. 282, no. 32, pp. 23645–23654, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. Y.-W. Lim, S.-Y. Yoon, J.-E. Choi et al., “Maintained activity of glycogen synthase kinase-3β despite of its phosphorylation at serine-9 in okadaic acid-induced neurodegenerative model,” Biochemical and Biophysical Research Communications, vol. 395, no. 2, pp. 207–212, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. W. Qian, J. Shi, X. Yin et al., “PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3β,” Journal of Alzheimer's Disease, vol. 19, no. 4, pp. 1221–1229, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Liu, I. Grundke-Iqbal, K. Iqbal, and C.-X. Gong, “Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation,” European Journal of Neuroscience, vol. 22, no. 8, pp. 1942–1950, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Martin, G. Page, and F. Terro, “Tau phosphorylation and neuronal apoptosis induced by the blockade of PP2A preferentially involve GSK3β,” Neurochemistry International, vol. 59, no. 2, pp. 235–250, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. I. de Baere, R. Derua, V. Janssens et al., “Purification of porcine brain protein phosphatase 2A leucine carboxyl methyltransferase and cloning of the human homologue,” Biochemistry, vol. 38, no. 50, pp. 16539–16547, 1999. View at Publisher · View at Google Scholar · View at Scopus